

Dr. Derajram Benival, Ph.D.
Associate Professor , Department of Pharmaceutics
-
National Institute of Pharmaceutical Education and Research-Ahmedabad -
derajram[at]niperahm[dot]ac[dot]in, derajram[at]niperahm[dot]res[dot]in -
+91 79-65181200
Research Interest
Research Area
- Intravitreal implants
- Long acting injectables
- Hot Melt Extrusion in Pharmaceuticals
- Protein and peptide delivery
Experience
- March 2025 - Present
Associate Professor
NIPER- Ahmedabad, Palaj, Gandhinagar
- March 2020 -March 2025
Assistant Professor
NIPER- Ahmedabad, Palaj, Gandhinagar
- May 2017 - March 2020
Manager 1
Formulation Research & Development,Sun Pharmaceutical Industries Ltd.Vadodara
- March 2015 – May 2017
Scientist E2 (Pharmaceutics)
Corporate Research & Development Centre, HLL Lifecare Ltd.,Thiruvananthapuram,Kerala
- March 2012 - March 2015
Research Officer
Formulation Development, Sun Pharma Advanced Research Company Ltd.Mumbai
Research Grant
- Title: “Hit to Lead Optimization of Adamantane-Quinoxalone Hybrids for the Precision Chemotherapy of Acute Myeloid Leukemia” (IIRPIG-2025-01-00800).
- Investigating Particles of Ciprofloxacin Injection by Otsuka.
- Development of long acting testosterone injection by StepsBio India Pvt. Ltd.
Publications
- Dhwani Rana, Sagar Salave, Derajram Benival. (2021). Emerging trends in Abuse-Deterrent Formulations: Technological insights and Regulatory considerations, Current Drug Delivery. DOI : 10.2174/1567201818666211208101035
- Dhwani Rana, Sagar Salave, Suraj Longare, Rishabh Agarwal, Kiran Kalia,
Benival D.M. (2021). Nanotherapeutics in Tumour Microenvironment for Cancer Therapy, Nanoscience & Nanotechnology-Asia. DOI : 10.2174/2210681211666210908144839 - Sagar Salave, Sonali Jain, Ambika Chamoli, Amit Mandoli, Ravi Shah, Kiran Kalia,Benival D.M,. (2020). Role Of Biologicals For Combating Covid-19: A Systematic Review, World Journal Of Pharmacy And Pharmaceutical Sciences,9(12),
456-484. DOI: 10.20959/wjpps202012-17770 - Benival D.M, and Devarajan Padma V. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability. International Journal of Pharmaceutics. 2012;423: 554–561 (Impact Factor: 4.213).
- Benival D.M, and Devarajan Padma V. In situ lipidization as a new approach for the design of a self microemulsifying drug delivery system (SMEDDS) of doxorubicin hydrochloride for oral administration.
Journal of Biomedical Nanotechnology. 2014; 10:1-10 ((Impact Factor: 5.068).
Research Grant
- Title: “Multimetal nanozyme complex, preparation process, and nanoformulation prepared thereof”,
Application No. 202621076098, 2026. - Title: “Polyherbal component containing slow eroding extrudate for treatment of mouth ulcer”,
Application No. 202321008552, 2023.

